The Department of Industrial Policy and Promotion (DIPP) of the Ministry of Commerce and Industry of the Government of India has recently initiated a public debate through a ‘Discussion Paper on Compulsory Licensing (CL) of Patented Pharmaceutical Products’. The key … Continue reading
Why does the Government divert focus on to fringe issues to address critical healthcare concerns of the nation?
Reply